{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Nuvation Bio Inc."},"Symbol":{"label":"Symbol","value":"NUVB"},"Address":{"label":"Address","value":"1500 BROADWAY,SUITE 1401, NEW YORK, New York, 10036, United States"},"Phone":{"label":"Phone","value":"+1 332 208-6102"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer."},"CompanyUrl":{"label":"Company Url","value":"https://www.nuvationbio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"David T. Hung","title":"President, Chief Executive Officer & Director"},{"name":"Dong Fang Liu","title":"Chief Medical Officer"},{"name":"Gary Hattersley","title":"Chief Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}